| HOME >> BIOLOGY >> TECHNOLOGY |
- FINANCIAL TABLES FOLLOW -
SKYSTAR BIO-PHARMACEUTICAL COMPANY AND SUBSIDIARY
CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2007 AND DECEMBER 31, 2006
ASSETS
June 30, December 31,
2007 2006
Unaudited
CURRENT ASSETS:
Cash $2,828,299 $192,016
Restricted cash 71,764 69,610
Accounts receivable, trade, net of allowance
for doubtful accounts of $11,870 and
$14,426 as of June 30, 2006 and December
31, 2006, respectively 312,380 131,599
Inventories 974,404 528,566
Deposits and prepaid expenses 549,544 29,944
Loans receivable 403,278 8,558
Other receivables 21,959 38,881
Other receivables- related party 64,594 -
Total current assets 5,226,222 999,174
PLANT AND EQUIPMENT, net 11,426,613 10,910,948
OTHER ASSETS:
Deferred debenture expense 817,524 -
Prepaid land use right, net 315,827 311,212
Intangible, net 15,342 25,640
Total other assets 1,148,693 336,852
Total assets $17,801,528 $12,246,974
CURRENT LIABILITIES:
Interest-bearing short-term loan $39
'/>"/>
SOURCE Skystar Bio-Pharmaceutical Co.![]() Copyright©2007 PR Newswire. |